Circulating Sclerostin and Irisin Are Related and Interact with Gender to Influence Adiposity in Adults with Prediabetes
Open Access
- 3 September 2014
- journal article
- research article
- Published by Hindawi Limited in International Journal of Endocrinology
- Vol. 2014, 1-6
- https://doi.org/10.1155/2014/261545
Abstract
Objectives. Sclerostin, an osteocyte-specific protein, has been found to be related to adiposity and glucose metabolism. Irisin, a myokine, can affect browning of white fat and influence glucose and energy homeostasis. Taken together, this suggests a probable network among fat, bone, and muscle that may influence health outcomes. The aims of this study were to investigate the relationship of circulating sclerostin and irisin and their association with adiposity (assessed by body mass index (BMI)). Materials/Methods. A cross-sectional study included 98 adults with impaired fasting glucose and/or impaired glucose tolerance. 75 gm OGTT was performed in all subjects. Fasting plasma samples were obtained for glycated hemoglobin, calcium, creatinine, serum sclerostin and irisin. Results. Circulating irisin and sclerostin were highly correlated . After controlling for age, gender, and BMI, irisin was significantly related to sclerostin . Multivariate linear regression analysis demonstrated that circulating sclerostin and irisin were negatively associated with BMI, independent of age in males. In females, no relationship of sclerostin or irisin to BMI was found. Conclusions. Circulating irisin and sclerostin are highly related. Interventions targeting irisin could affect sclerostin and vice versa.Funding Information
- Mahidol University
This publication has 29 references indexed in Scilit:
- Longitudinal variation of circulating irisin after an energy restriction‐induced weight loss and following weight regain in obese men and womenAmerican Journal of Human Biology, 2013
- Irisin, Two Years LaterInternational Journal of Endocrinology, 2013
- Inducible Brown Adipose Tissue, or Beige Fat, Is Anabolic for the SkeletonEndocrinology, 2013
- Standards of Medical Care in Diabetes—2013Diabetes Care, 2012
- Patients with primary hyperparathyroidism have lower circulating sclerostin levels than euparathyroid controlsActa Endocrinologica, 2010
- Relation of age, gender, and bone mass to circulating sclerostin levels in women and menJournal of Bone and Mineral Research, 2010
- Sclerostin: Current Knowledge and Future PerspectivesCalcified Tissue International, 2010
- Serum Sclerostin Levels Negatively Correlate with Parathyroid Hormone Levels and Free Estrogen Index in Postmenopausal WomenJournal of Clinical Endocrinology & Metabolism, 2010
- From mechanostat theory to development of the "Functional Muscle-Bone-Unit".2005
- Effects of estradiol with and without testosterone on body composition and relationships with lipids in postmenopausal womenMenopause, 2000